BioVie Inc. Interest Expense
BioVie Inc. (BIVI) reported Interest Expense of $17.90 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-13.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-08-13
- BioVie Inc. interest expense for the quarter ending 2026-06-30 was $3.98K, a 20.41% decline year-over-year.
- BioVie Inc. interest expense for the quarter ending 2026-03-31 was $5.97K, a 19.39% increase year-over-year.
- BioVie Inc. interest expense for the quarter ending 2025-12-31 was $5.97K, a 91.05% decline year-over-year.
- BioVie Inc. interest expense for the quarter ending 2025-09-30 was $1.99K, a 99.22% decline year-over-year.
- BioVie Inc. interest expense for fiscal 2026 was $17.90K, a 94.62% decline from fiscal 2025.
- BioVie Inc. interest expense for fiscal 2025 was $332.72K.
- BioVie Inc. interest expense for fiscal 2023 was $4.30M, a 98.81% increase from fiscal 2022.
- BioVie Inc. interest expense for fiscal 2022 was $2.16M, a 286.62% increase from fiscal 2021.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $3.98K derived: 10-K 12 month − S-1/A 9 month · filed 2026-08-13 | $9.95K derived: sum of 2 quarters · filed 2026-08-13 | $15.91K derived: sum of 3 quarters · filed 2026-08-13 | $17.90K 10-K · filed 2026-08-13 | |
| 2026-03-31 | $5.97K S-1/A · filed 2026-08-06 | $11.93K derived: sum of 2 quarters · filed 2026-08-06 | $13.92K S-1/A · filed 2026-08-06 | $18.92K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | $5.97K 10-Q · filed 2026-02-06 | $7.96K 10-Q · filed 2026-02-06 | $12.95K derived: sum of 3 quarters · filed 2026-08-13 | $17.95K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-09-30 | $1.99K derived: 10-K 12 month − 3 quarters · filed 2026-08-13 | $6.99K derived: sum of 2 quarters · filed 2026-08-13 | $11.98K derived: sum of 3 quarters · filed 2026-08-13 | $78.69K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | $5.00K derived: 10-K 12 month − S-1/A 9 month · filed 2026-08-13 | $10.00K derived: sum of 2 quarters · filed 2026-08-13 | $76.70K derived: sum of 3 quarters · filed 2026-08-13 | $332.72K 10-K · filed 2026-08-13 | |
| 2025-03-31 | $5.00K S-1/A · filed 2026-08-06 | $71.70K derived: sum of 2 quarters · filed 2026-08-06 | $327.72K S-1/A · filed 2026-08-06 | $767.66K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2024-12-31 | $66.70K 10-Q · filed 2026-02-06 | $322.73K 10-Q · filed 2026-02-06 | $762.67K derived: sum of 3 quarters · filed 2026-08-06 | $1.39M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2024-09-30 | $256.02K 10-Q · filed 2024-11-13 | $695.97K derived: sum of 2 quarters · filed 2026-08-06 | $1.32M derived: sum of 3 quarters · filed 2026-08-06 | $2.15M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2024-06-30 | $439.94K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-06 | $1.07M derived: sum of 2 quarters · filed 2026-08-06 | $1.89M derived: sum of 3 quarters · filed 2026-08-06 | $2.89M S-1/A · filed 2026-08-06 | |
| 2024-03-31 | $628.71K 10-Q · filed 2024-05-14 | $1.45M derived: sum of 2 quarters · filed 2024-05-14 | $2.45M 10-Q · filed 2024-05-14 | $3.56M derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-12-31 | $820.60K 10-Q · filed 2024-02-13 | $1.83M 10-Q · filed 2024-02-13 | $2.93M derived: sum of 3 quarters · filed 2024-11-13 | $4.02M derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-09-30 | $1.00M 10-Q · filed 2024-11-13 | $2.11M derived: sum of 2 quarters · filed 2024-11-13 | $3.19M derived: sum of 3 quarters · filed 2024-11-13 | $4.25M derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-06-30 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $2.19M derived: sum of 2 quarters · filed 2024-09-30 | $3.24M derived: sum of 3 quarters · filed 2024-09-30 | $4.30M 10-K · filed 2024-09-30 | |
| 2023-03-31 | $1.08M 10-Q · filed 2024-05-14 | $2.14M derived: sum of 2 quarters · filed 2024-05-14 | $3.19M 10-Q · filed 2024-05-14 | $4.12M derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $1.05M 10-Q · filed 2024-02-13 | $2.11M 10-Q · filed 2024-02-13 | $3.04M derived: sum of 3 quarters · filed 2024-02-13 | $3.96M derived: sum of 4 quarters · filed 2024-02-13 | |
| 2022-09-30 | $1.06M 10-Q · filed 2023-11-08 | $1.98M derived: sum of 2 quarters · filed 2023-11-08 | $2.90M derived: sum of 3 quarters · filed 2023-11-08 | $3.22M derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | $926.98K derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-16 | $1.85M derived: sum of 2 quarters · filed 2023-08-16 | $2.16M derived: sum of 3 quarters · filed 2023-08-16 | $2.16M 10-K · filed 2023-08-16 | |
| 2022-03-31 | $918.63K 10-Q · filed 2023-05-12 | $1.23M derived: sum of 2 quarters · filed 2023-05-12 | $1.24M 10-Q · filed 2023-05-12 | $1.24M derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | $316.26K 10-Q · filed 2023-02-10 | $317.38K 10-Q · filed 2023-02-10 | $317.38K derived: sum of 3 quarters · filed 2023-02-10 | $317.38K derived: sum of 4 quarters · filed 2023-02-10 | |
| 2021-09-30 | $1.11K 10-Q · filed 2022-11-04 | $1.11K derived: sum of 2 quarters · filed 2022-11-04 | $1.11K derived: sum of 3 quarters · filed 2022-11-04 | $1.26K derived: sum of 4 quarters · filed 2022-11-04 | |
| 2021-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | $0.00 derived: sum of 2 quarters · filed 2022-09-27 | $143.00 derived: sum of 3 quarters · filed 2022-09-27 | $559.46K 10-K · filed 2022-09-27 | |
| 2021-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-11 | $143.00 derived: sum of 2 quarters · filed 2022-05-11 | $559.46K 10-Q · filed 2022-05-11 | $1.80M derived: sum of 4 quarters · filed 2022-05-11 | |
| 2020-12-31 | $143.00 10-Q · filed 2022-02-08 | $559.46K 10-Q · filed 2022-02-08 | $1.80M derived: sum of 3 quarters · filed 2022-02-08 | $1.83M derived: sum of 4 quarters · filed 2022-02-08 | |
| 2020-09-30 | $559.31K 10-Q · filed 2021-11-10 | $1.80M derived: sum of 2 quarters · filed 2021-11-10 | $1.83M derived: sum of 3 quarters · filed 2021-11-10 | $1.85M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-30 | $1.27M derived: sum of 2 quarters · filed 2021-08-30 | $1.29M derived: sum of 3 quarters · filed 2021-08-30 | $4.77M 10-K · filed 2021-08-30 | |
| 2020-03-31 | $33.70K 10-Q · filed 2021-05-10 | $54.62K derived: sum of 2 quarters · filed 2021-05-10 | $3.53M 10-Q · filed 2021-05-10 | $3.53M derived: sum of 4 quarters · filed 2021-05-10 | |
| 2019-12-31 | $20.92K 10-Q · filed 2021-01-29 | $3.50M 10-Q · filed 2021-01-29 | $3.50M derived: sum of 3 quarters · filed 2021-01-29 | $3.50M derived: sum of 4 quarters · filed 2021-01-29 | |
| 2019-09-30 | $3.48M 10-Q · filed 2020-11-05 | $3.48M derived: sum of 2 quarters · filed 2020-11-05 | $3.48M derived: sum of 3 quarters · filed 2020-11-05 | $3.48M derived: sum of 4 quarters · filed 2020-11-05 | |
| 2019-06-30 | $1.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-08-07 | $2.00 derived: sum of 2 quarters · filed 2020-08-07 | $1.00 derived: sum of 3 quarters · filed 2020-08-07 | $273.00 10-K/A · filed 2020-08-07 | |
| 2019-03-31 | $1.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-13 | $0.00 derived: sum of 2 quarters · filed 2020-05-13 | $272.00 10-Q · filed 2020-05-13 | $31.40K derived: sum of 4 quarters · filed 2020-05-13 | |
| 2018-12-31 | -$1.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-13 | $271.00 10-Q · filed 2020-02-13 | $31.40K derived: sum of 3 quarters · filed 2020-02-13 | $32.74K derived: sum of 4 quarters · filed 2020-02-13 | |
| 2018-09-30 | $272.00 10-Q · filed 2019-11-19 | $31.40K derived: sum of 2 quarters · filed 2019-11-19 | $32.75K derived: sum of 3 quarters · filed 2019-11-19 | $40.62K derived: sum of 4 quarters · filed 2019-11-19 | |
| 2018-06-30 | $31.13K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-27 | $32.47K derived: sum of 2 quarters · filed 2019-09-27 | $40.35K derived: sum of 3 quarters · filed 2019-09-27 | $40.96K 10-K · filed 2019-09-27 | |
| 2018-03-31 | $1.34K 10-Q · filed 2019-05-10 | $9.22K derived: sum of 2 quarters · filed 2019-05-10 | $9.83K 10-Q · filed 2019-05-10 | ||
| 2017-12-31 | $7.88K 10-Q · filed 2019-02-12 | $8.48K 10-Q · filed 2019-02-12 | $8.49K 10-Q · filed 2018-02-14 | ||
| 2017-09-30 | $611.00 10-Q · filed 2018-11-14 | ||||
| 2016-06-30 | $81.00 10-K · filed 2017-08-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |